國家衛生研究院 NHRI:Item 3990099045/14646
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 854389      在线人数 : 608
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻
    主页登入上传说明关于NHRI管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/14646


    题名: Long-term outcomes of the pay-for-performance program for patients with young-onset (20–40 years of age) type 2 diabetes
    作者: Yen, FS;Wei, JCC;Hung, YT;Hsu, CC;Hwu, CM
    贡献者: National Center for Geriatrics and Welfare Research;Institute of Population Health Sciences
    摘要: Aims: To investigate the long-term outcomes of Pay-for-Performance (P4P) care in patients with young-onset (20–40 years of age) diabetes (YOD). Methods: We recruited 3088 pairs of propensity-score matched patients with and without P4P care from the National Health Insurance Research Database between January 1, 2001, and December 31, 2017. The study used a multivariable Cox regression model to compare the risks of mortality, hospitalization for cardiovascular events, and major microvascular outcomes in YOD patients with and without P4P care. Results: The multivariable-adjusted model showed that patients with P4P care had significantly lower risks of mortality (aHR 0.31, 95% CI 0.25–0.38) and hospitalization for cardiovascular events (aHR 0.63, 95% CI 0.5–0.79) but a significantly higher risk of major microvascular outcomes (aHR 1.31, 95% CI 1.07–1.6). Patients with a longer cumulative duration of P4P and complete P4P care showed further lower risks of mortality, hospitalization for cardiovascular events, and major microvascular outcomes than those without P4P care. Conclusions: This nationwide cohort study showed that young-onset diabetes patients with P4P care had lower risks of death and cardiovascular events but a higher risk of major microvascular outcomes. However, patients with a longer duration of P4P care showed lower risks of these outcomes.
    日期: 2022-11
    關聯: Diabetes Research and Clinical Practice. 2022 Nov;193:Article number 110136.
    Link to: http://dx.doi.org/10.1016/j.diabres.2022.110136
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0168-8227&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000891798300008
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85141263315
    显示于类别:[許志成] 期刊論文
    [許志成] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    SCP85141263315.pdf416KbAdobe PDF110检视/开启


    在NHRI中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈